Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul 4:5:281.
doi: 10.1186/1752-1947-5-281.

Severe isolated thrombocytopenia after clopidogrel and pentoxifylline therapy: a case report

Affiliations

Severe isolated thrombocytopenia after clopidogrel and pentoxifylline therapy: a case report

Elisa Celeste da Silva Vedes et al. J Med Case Rep. .

Abstract

Introduction: Clopidogrel is frequently associated with thrombotic thrombocytopenic purpura, however this drug is rarely related to severe isolated thrombocytopenia. Pentoxifylline has previously been associated with thrombocytopenia only once. To the best of our knowledge, this is the first report of severe isolated thrombocytopenia after therapy with both clopidogrel and pentoxyfilline.

Case presentation: We report the case of a 79-year-old Caucasian man who presented to our facility with intermittent claudication. He had obliterative arterial disease and started therapy with clopidogrel and pentoxifylline. His basal platelet count was 194 × 109 cells/L. At three days after the start of treatment, our patient had lower limb petechia and stopped taking clopidogrel and pentoxifylline. His platelet count lowered to 4 × 109 cells/L and our patient was admitted to hospital. Our patient had purpura with no other hemorrhages or splenomegaly. Results of a blood smear were normal, and a bone marrow study showed dysmegakaryopoiesis. Antiplatelet antibody test results were negative, as were all viral serology tests. Imaging study results were normal. Our patient was given immunoglobulin but there was no sustained platelet increase, so corticotherapy was started as the next treatment step. At five months after clopidogrel and pentoxifylline were discontinued, his platelet count continued increasing even after prednisolone was tapered.

Conclusions: Severe isolated thrombocytopenia may appear as a side effect when using clopidogrel and pentoxifylline. These drugs are widely used by general physicians, internists, cardiologists and vascular surgeons. We hope this report will raise awareness of the need to monitor the platelet count in patients taking these drugs.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Platelet count after the beginning of anti-thrombotic therapy with clopidogrel and pentoxifylline. The arrows mark the dates when immunoglobulin and corticotherapy were started.
Figure 2
Figure 2
Platelet count including follow-up after hospital discharge.

References

    1. Creager MA. Results of the CAPRIE trial: efficacy and safety of clopidogrel. Clopidogrel versus aspirin in patients at risk of ischaemic events. Vasc Med. 1998;3:257–260. - PubMed
    1. Van De Graaff E, Steinhubl SR. Complications of oral antiplatelet medications. Curr Cardiol Rep. 2001;3:371–379. doi: 10.1007/s11886-001-0053-6. - DOI - PubMed
    1. Su CH, Tsai CF, Ueng KC, Shiao PG, Lin CS, Chen KS, Lin MC, Wu DJ, Lin CS. Clopidogrel-associated severe isolated thrombocytopenia - a case report. Acta Cardiol Sin. 2004;20:182–186.
    1. Elmi F, Peacock T, Schiavone J. Isolated profound thrombocytopenia associated with clopidogrel. J Invas Cardiol. 2000;12:532–535. - PubMed
    1. Helft G, Elalamy I, Laudy C, Tran D, Beygui F, Le Feuvre C, Ounissi F, Monnet de Lorbeau B, Khellaf C, Metzger JP. Clopidogrel and thrombopenia. A case report. Ann Cardiol Angeiol. 2003;52:191–193. doi: 10.1016/S0003-3928(02)00185-3. - DOI - PubMed

LinkOut - more resources